Hematopoietic progenitor cells from patients with myelodysplastic syndromes: In vitro colony growth and long-term proliferation

Leukemia Research

Volumn 23, Issue 4, 1999, Pages 385-394

  Flores Figueroa, Eugenia ^a   Gutiérrez Espindola, Guillermo ^b   Guerrero Rivera, Susana ^b   Pizzuto Chavez, Javier ^b   Mayani, Hector ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b Bernardo Sepulveda Hospital   (Mexico)

Author keywords

Hematopoiesis; In vitro; Long term cultures; Myelodysplasia; Progenitor cells; Proliferation

Indexed keywords

INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CELL ADHESION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMATION; FEMALE; GENETIC TRANSFORMATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTE; REFRACTORY ANEMIA;

EID: 0344076163     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00176-3     Document Type: Article

References (32)

1. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities and clinical implications. J. Clin. Pathol. 38:1985;1201.
2. Greenberg P.L. The smoldering myeloid leukemic states. Clinical and biologic features. Blood. 61:1983;1035.
3. Resegotti L. The nature and natural history of myelodysplasia. Haematologica. 5:1993;191.
4. Mayani H. Human preleukemia: cellular, molecular and clinical aspects. Arch. Med. Res. 24:1993;317.
5. Weimar S., Bourhis J.-H., Gast G.C.D., Gerristen W.R. Clonality in myelodysplastic syndromes. Leuk. Lymphoma. 13:1993;215.
6. Jacobs A. Genetic lesions in preleukemia. Leukemia. 5:1991;277.
7. Raza A., Mundle S., Shetty V., Alvi S., Chopra H., Span L., Parcharidou A., Dar S., Venugopal P., Borok R., Gezer S., Showel J., Loew J., Robin E., Rifkin S., Alston D., Hernandez B., Shah R., Kaizer H., Gregory S., Preisler H. A paradigm shift in myelodysplastic syndromes. Leukemia. 10:1996;1648.
8. Jacobs A. Human preleukemia: do we have a model? Br. J. Cancer. 55:1987;1.
9. Greenberg P.L., Mara B. The preleukemic syndrome. Correlation of in vitro parameters with clinical features. Am. J. Med. 66:1979;951.
10. Yoshida Y. Biology of myelodysplastic syndromes. Int. J. Cell. Cloning. 5:1987;356.
11. Dan K., An E., Futaki M., Inokuchi K., Gomi S., Yamada T., Ogata K., Tanabe Y., Ohki I., Shinohara T., Nomura T. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta. Haematol. 89:1993;113.
12. Ruutu T., Partanen S., Lintula R., Teerenhovi L., Knuutila S. Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand. J. Haematol. 32:1984;395.
13. Yoshida Y., Yoshida C., Tohyama K., Ohmori S., Ohmori M., Ueda Y., Taniguchi Y., Uchino H. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes. Leuk. Res. 13:1989;967.
14. Merchav S., Wagemaker G., Souza L.M., Tatarsky I. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant hemopoietic growth factors. Leukemia. 5:1991;340.
15. Mayani H., Baines P., Bowen D.T., Jacobs A. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia. 3:1989;29.
16. Schipperus M.R., Sonneveld P., Lindemans J., Vink N., Vlastuin M., Hagemeijer A., Abels J. The combined effects of IL-3, GM-CSF, and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells. Leuk. Res. 14:1990;1019.
17. Thomas X., Guyotat D., Campos L., Shi Z.H., Vila L., Ehrsam A., Fiere D. In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplstic syndromes. Leuk. Res. 15:1991;29.
18. Masters G.S., Baines P., Tang C., Bowen D., Burnett A.K. Responsiveness to stem cell factor (SCF) of peripheral blood colony-forming cells from patients with myelodysplastic syndromes (MDS). Leuk. Res. 19:1995;561.
19. Coutinho L.H., Geary C.G., Chang J., Harrison C., Testa N.G. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br. J. Haematol. 75:1990;16.
20. Borbenyi Z., Cinkotai C., Harrison C., Testa N.G. The growth of myelodysplastic bone marrow in long-term cultures. Br. J. Cancer. 55:1987;291.
21. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189.
22. Mayani H., Guilbert L.J., Janowska-Wieczorek A. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures. Exp. Hematol. 18:1990;174.
23. Mayani H., Gutierrez-Rodriguez M., Espinoza L., Lopez-Chalini E., Huerta-Zepeda A., Flores E., Sánchez-Valle E., Luna-Bautista F., Valencia I., Ramírez O.T. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells. Stem Cells. 16:1998;127.
24. Worsley A., Oscier D.G., Stevens J. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br. J. Haematol. 68:1988;17.
25. Coulombel L., Eaves A.C., Eaves C.J. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood. 62:1983;291.
26. Bhatia R., Wayner E.A., McGlave P.B., Verfaillie C.M. Interferon α restores normal adhesión of chronic myelogenous leukemia progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J. Clin. Invest. 94:1994;384.
27. Mayani H. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia. 10:1996;1041.
28. Gidali J., Feher I., Hollan S.R. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients. Stem Cells. 14:1996;577.
29. Mayer R.J., Canellos G.P. Primary myelodysplastic syndrome and secondary preleukemic disorders. Henderson E.S., Lister T.A., Greaves M.F. Leukemiae. 6th Edition:1996;513-534 Saunders, Philadelphia, PA.
30. Coulombel L., Kalousek D., Eaves C.J., Eaves A.C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New. Engl. J. Med. 308:1983;1493.
31. Coulombel L., Eaves C.J., Kalousek D., Gupta C., Eaves A.C. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotype in some but not all cases. J. Clin. Invest. 75:1985;961.
32. Mayani H., Shen S., Guilbert L.J., Clark S.C., Sych I., Janowska-Wieczorek A. Effect of rhCSF-1 on human hemopoiesis in long-term cultures from patients with acute myelogenous leukemia. Leukemia. 5:1991;8.